Kirk Mclean

838 total citations
16 papers, 610 citations indexed

About

Kirk Mclean is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, Kirk Mclean has authored 16 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Kirk Mclean's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Marine Bivalve and Aquaculture Studies (2 papers). Kirk Mclean is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Marine Bivalve and Aquaculture Studies (2 papers). Kirk Mclean collaborates with scholars based in United States and Germany. Kirk Mclean's co-authors include John Morser, William H. Andrews, David R. Light, Charles B. Glaser, Eric Blasko, Irene Kuhn, Tish Young, Robert Wydro, Jianhua Lin and Sabine Schirm and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Kirk Mclean

16 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirk Mclean United States	11	295	179	113	106	86	16	610
JL McGregor France	10	353 1.2×	110 0.6×	46 0.4×	144 1.4×	55 0.6×	15	616
Stephen F. Garner United Kingdom	18	570 1.9×	102 0.6×	32 0.3×	112 1.1×	115 1.3×	54	854
Aruna B. Pawashe United States	10	355 1.2×	137 0.8×	95 0.8×	117 1.1×	22 0.3×	12	563
EM Bevers Netherlands	10	359 1.2×	290 1.6×	30 0.3×	47 0.4×	45 0.5×	11	798
John D. Iuliucci United States	13	122 0.4×	316 1.8×	25 0.2×	90 0.8×	119 1.4×	16	637
M Zushi Japan	9	622 2.1×	185 1.0×	248 2.2×	216 2.0×	99 1.2×	10	853
Helena M. Jacobs United States	9	115 0.4×	180 1.0×	89 0.8×	51 0.5×	37 0.4×	10	722
G. van Dieijen Netherlands	13	787 2.7×	393 2.2×	56 0.5×	65 0.6×	143 1.7×	23	1.2k
Sonia Águila Spain	16	450 1.5×	207 1.2×	61 0.5×	88 0.8×	81 0.9×	40	760
June Li United States	17	654 2.2×	220 1.2×	34 0.3×	77 0.7×	63 0.7×	37	1.0k

Countries citing papers authored by Kirk Mclean

Since Specialization

Citations

This map shows the geographic impact of Kirk Mclean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Mclean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Mclean more than expected).

Fields of papers citing papers by Kirk Mclean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Mclean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Mclean. The network helps show where Kirk Mclean may publish in the future.

Co-authorship network of co-authors of Kirk Mclean

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Mclean. A scholar is included among the top collaborators of Kirk Mclean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Mclean. Kirk Mclean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhao, Xiaoyan, Subramanian Yegneswaran, Maxine Bauzon, et al.. (2016). Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia. Blood. 128(22). 80–80. 9 indexed citations

Leder, Gabriele, Lars Lindén, Sven Golfier, et al.. (2013). Abstract LB-206: Target validation of C4.4a (LYPD3) as a target for antibody-drug conjugates for the treatment of squamous cell carcinoma of different origin.. Cancer Research. 73(8_Supplement). LB–206. 1 indexed citations

Alicke, Bruno, David R. Light, Kirk Mclean, et al.. (2009). In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of ⁸⁶Y- and ¹¹¹In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice. Journal of Nuclear Medicine. 50(3). 435–443. 62 indexed citations

Satozawa, Noboru, Kirk Mclean, David Vogel, et al.. (2006). Obligate Multivalent Recognition of Cell Surface Tomoregulin following Selection from a Multivalent Phage Antibody Library. SLAS DISCOVERY. 11(8). 985–995. 7 indexed citations

Wu, Chengliang, et al.. (2006). Amplified anticoagulant activity of tissue factor-targeted thrombomodulin. Thrombosis and Haemostasis. 96(9). 317–324. 13 indexed citations

Xia, Wei, Peter Bringmann, John McClary, et al.. (2005). High levels of protein expression using different mammalian CMV promoters in several cell lines. Protein Expression and Purification. 45(1). 115–124. 65 indexed citations

Mclean, Kirk, Sabine Schirm, Anthony Johns, John Morser, & David R. Light. (2001). FXa-Induced Responses in Vascular Wall Cells are PAR-Mediated and Inhibited by ZK-807834. Thrombosis Research. 103(4). 281–297. 45 indexed citations

Light, David R., Charles B. Glaser, Eric Blasko, et al.. (1999). The interaction of thrombomodulin with Ca²⁺. European Journal of Biochemistry. 262(2). 522–533. 25 indexed citations

Lin, Jianhua, Kirk Mclean, John Morser, et al.. (1994). Modulation of glycosaminoglycan addition in naturally expressed and recombinant human thrombomodulin.. Journal of Biological Chemistry. 269(40). 25021–25030. 69 indexed citations

10.

Light, David R., Eric Blasko, John F. Parkinson, et al.. (1993). The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function.. Journal of Biological Chemistry. 268(9). 6309–6315. 52 indexed citations

11.

Glaser, Charles B., John Morser, Eric Blasko, et al.. (1992). Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation.. Journal of Clinical Investigation. 90(6). 2565–2573. 208 indexed citations

12.

Mclean, Kirk, et al.. (1990). Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase. Thrombosis Research. 58(4). 421–433. 24 indexed citations

13.

Mclean, Kirk, et al.. (1979). Teacher Training for Teaching Assistants. The American Biology Teacher. 41(3). 140–187. 10 indexed citations

14.

Mclean, Kirk. (1976). Some Aspects of RNA Synthesis in Oyster Development. American Zoologist. 16(3). 521–528. 2 indexed citations

15.

Mclean, Kirk & Arthur H. Whiteley. (1974). Characteristics of DNA from the oyster, Crassostrea gigas. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 335(1). 35–41. 10 indexed citations

16.

Mclean, Kirk & Arthur H. Whiteley. (1974). RNA synthesis during the early development of the pacific oyster,. Experimental Cell Research. 87(1). 132–138. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact